Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.

FDA Approves Sapien 3, CoreValve Evolut TAVR Valves for Low-risk Patients

Left, an illustration of the beginning of deployment for a CoreValve Evolut self-expanding transcatheter aortic replacement (TAVR) valve. Right, an illustration of the final balloon expansion of an Edwards Lifesciences Sapien 3 TAVR valve. Both valves received simultaneous FDA clearance for use in low-risk surgical patients. Clearing this last hurdle now allows wide-spread use of minimally invasive TAVR in all patients who otherwise would need an open-heart surgical valve replacement. 

Feature | Heart Valve Technology | August 16, 2019 | Jeff Zagoudis, Associate Editor, and Dave Fornell, Editor

August 16, 2019 — In one coordinated move, the U.S. Food and Drug Administration (FDA) opened use of ...

Example of an aortic valve CT imaging workup for TAVR valve sizing and assessing access routes. This patient has an aneurism in the aortic arch. Image from GE Healthcare.

Example of an aortic valve CT imaging workup for TAVR valve sizing and assessing access routes. This patient has an aneurism in the aortic arch. Image from GE Healthcare.

Feature | Structural Heart | August 12, 2019 | Ashish Pershad, M.D., and Kenith Fang, M.D., FACS

As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the...

Filterlex Medical Raises $3 Million in Series A Financing for Embolic Protection Device
News | Embolic Protection Devices | July 19, 2019

July 19, 2019 — Medical device startup company Filterlex Medical recently completed a series A financing round,...

Abbott Receives U.S. Approval of Next-generation MitraClip G4
Technology | Heart Valve Technology | July 17, 2019

July 17, 2019 — Abbott has received U.S. Food and Drug Administration (FDA) approval for the most advanced MitraClip...

Neovasc Tiara, Reducer Transcatheter Devices Featured at CSI Frankfurt 2019 Conference
News | Heart Valve Technology | July 09, 2019

July 9, 2019 — Neovasc Inc. announced that its Tiara...

AI Algorithm Assists in Detection of Aortic Stenosis
News | Stethoscopes | July 08, 2019

July 8, 2019 — Berkeley, Calif.-based digital health company Eko unveiled an investigational...

FEops HEARTguide Wins CSI Highlight of the Year Award
News | Structural Heart | July 05, 2019

July 5, 2019 — FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by...

Study Shows Inducing a Heart Attack Helps Valve Patients. This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates some of the tissue in the septum to allow for a larger LVOT area.

This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates (kills) some of the tissue in the cardiac septum to allow these valves to fit better and allow for an enlarged neo-LVOT for patients who otherwise could not receive this therapy. 

News | Heart Valve Technology | July 03, 2019

July 3, 2019 — A ...

CMS Finalizes Updates to Coverage Policy for Transcatheter Aortic Valve Replacement
Feature | Heart Valve Technology | June 24, 2019

June 24, 2019 — The Centers for Medicare and Medicaid Services (CMS) recently finalized its decision to update the...

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019

June 20, 2019 – VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between...

Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019

June 13, 2019 — Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food...

Abbott Tricuspid Valve Repair System Reduces Tricuspid Regurgitation at 30 Days
News | Heart Valve Technology | June 11, 2019

June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE...

DSM and SAT Partnering to Develop Next-Generation, Cost-Effective Heart Valve
News | Heart Valve Technology | June 04, 2019

June 4, 2019 — Royal DSM recently announced a collaboration with Strait Access Technologies (SAT), to develop the...

Overlay Init